BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3310610)

  • 1. Expression of the Leu-8 antigen by B-cell lymphomas.
    Michie SA; Garcia CF; Strickler JG; Dailey MO; Rouse RV; Warnke RA
    Am J Clin Pathol; 1987 Oct; 88(4):486-90. PubMed ID: 3310610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Tac antigen by non-Hodgkin's lymphomas.
    Weiss LM; Michie SA; Medeiros LJ; Strickler JG; Garcia CF; Warnke RA
    Am J Clin Pathol; 1987 Oct; 88(4):483-5. PubMed ID: 2821794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.
    Burns BF; Warnke RA; Doggett RS; Rouse RV
    Am J Pathol; 1983 Nov; 113(2):165-71. PubMed ID: 6605688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the activation antigen, 4F2, by non-Hodgkin's lymphomas of B-cell phenotype.
    Lewandrowski KB; Medeiros LJ; Harris NL
    Cancer; 1990 Sep; 66(6):1158-64. PubMed ID: 1698116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic reticulum cells and immunophenotype in aspiration biopsies of lymph nodes. Value in the subclassification of non-Hodgkin's lymphomas.
    Kornstein MJ; Wakely PE; Kardos TF; Frable WJ
    Am J Clin Pathol; 1990 Aug; 94(2):165-9. PubMed ID: 2196777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience.
    Borowitz MJ; Bousvaros A; Brynes RK; Cousar JB; Crissman JD; Whitcomb CC; Kerns BJ; Byrne GE
    Am J Pathol; 1985 Dec; 121(3):514-21. PubMed ID: 2933960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.
    Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H
    Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bcl-2 gene is rearranged in many diffuse B-cell lymphomas.
    Aisenberg AC; Wilkes BM; Jacobson JO
    Blood; 1988 Apr; 71(4):969-72. PubMed ID: 2965608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate lymphocytic lymphoma: an immunohistologic study with comparison to other lymphocytic lymphomas.
    Weisenburger DD; Linder J; Daley DT; Armitage JO
    Hum Pathol; 1987 Aug; 18(8):781-90. PubMed ID: 3301625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoperoxidase staining of non-Hodgkin's lymphomas for T-cell lineage associated antigens in paraffin sections. Comparison of the performance characteristics of four commercially available antibody preparations.
    Kurtin PJ; Roche PC
    Am J Surg Pathol; 1993 Sep; 17(9):898-904. PubMed ID: 8352374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Leu-8 surface antigen in B-cell lymphomas. Correlation with other B-cell markers.
    Carbone A; Manconi R; Poletti A; Gloghini A; De Paoli P; Volpe R
    J Pathol; 1988 Feb; 154(2):133-40. PubMed ID: 3258374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic characterization of follicle-center-cell-derived non-Hodgkin's lymphomas.
    Sakthivel R; Christensson B; Ehlin-Henriksson B; Klein G
    Int J Cancer; 1989 Apr; 43(4):624-30. PubMed ID: 2649442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.
    Weiss LM; Crabtree GS; Rouse RV; Warnke RA
    Am J Pathol; 1985 Feb; 118(2):316-24. PubMed ID: 3155915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
    Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
    Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Tac antigen in B cell lymphomas.
    Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
    Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.